228 related articles for article (PubMed ID: 17634060)
1. Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy.
Pieribone VA; Tsai J; Soufflet C; Rey E; Shaw K; Giller E; Dulac O
Epilepsia; 2007 Oct; 48(10):1870-4. PubMed ID: 17634060
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
3. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
4. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
5. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures.
Sperling MR; Klein P; Tsai J
Epilepsia; 2017 Apr; 58(4):558-564. PubMed ID: 28230252
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam: a long-term follow-up study of efficacy and safety.
Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
[TBL] [Abstract][Full Text] [Related]
10. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of zonisamide in refractory childhood-onset epilepsy.
Kluger G; Zsoter A; Holthausen H
Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
Reddy DS; Rogawski MA
J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
[TBL] [Abstract][Full Text] [Related]
13. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
14. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial.
Kerrigan JF; Shields WD; Nelson TY; Bluestone DL; Dodson WE; Bourgeois BF; Pellock JM; Morton LD; Monaghan EP
Epilepsy Res; 2000 Dec; 42(2-3):133-9. PubMed ID: 11074186
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
Wroe SJ; Yeates AB; Marshall A
Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
[TBL] [Abstract][Full Text] [Related]
16. Practical prescribing and long-term efficacy and safety of zonisamide.
Leppik IE
Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
Genton P; Sadzot B; Fejerman N; Peltola J; Despland PA; Steinhoff B; Rektor I; Wroe S; Maubrey MC; Vandervelden C; van Hammée G; Schlit AF; van Paesschen W
Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel C; Holthausen H; Kluger G
Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of tiagabine: a prospective open-label study.
Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]